Deploys growth and buyout capital into software and healthcare companies across North America, emphasizing operational value creation, revenue acceleration and disciplined exit timelines. Christopher H. Gardner serves as a private equity principal and board director with experience sourcing proprietary deal flow, structuring transactions and leading portfolio company transformations. He maintains LP relationships, oversees fund economics and collaborates with management teams to scale margins and prepare assets for strategic or public sale.
Deploys growth and buyout capital into software and healthcare companies across North America, emphasizing operational value creation, revenue acceleration and disciplined exit timelines. Christopher H. Gardner serves as a private equity principal and board director with experience sourcing proprietary deal flow, structuring transactions and leading portfolio company transformations. He maintains LP relationships, oversees fund economics and collaborates with management teams to scale margins and prepare assets for strategic or public sale.
Focuses on deploying growth and buyout capital into North American software and healthcare businesses, prioritizing operational value creation, revenue acceleration and margin expansion. Combines proprietary sourcing and disciplined underwriting with hands-on portfolio operational work—restructuring go-to-market, optimizing unit economics and aligning management incentives—to drive scalable EBITDA growth and predictable exit timing. Maintains LP and board engagement to manage fund economics and execute strategic or public sale paths.
Focuses on deploying growth and buyout capital into North American software and healthcare businesses, prioritizing operational value creation, revenue acceleration and margin expansion. Combines proprietary sourcing and disciplined underwriting with hands-on portfolio operational work—restructuring go-to-market, optimizing unit economics and aligning management incentives—to drive scalable EBITDA growth and predictable exit timing. Maintains LP and board engagement to manage fund economics and execute strategic or public sale paths.
| Trades 440 | Longs Won 339/440 77% | Profit Factor 57.87 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $808,398.08 |
| Average Win $232,610.85 | Best Trade (Jul 16) $8.75M | Sharpe Ratio -29.44 |
| Average Loss -$13,490.96 | Worst Trade (Jul 15) -$363,656.12 | Z-Score 22 (100%) |
| Commissions $0 | Avg. Trade Length 9m 3w 6d | Expectancy $176,119.3 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 33,333 | 30,000 | 26,667 | 23,333 | 20,000 | 16,667 | 13,333 | 10,000 | 6,667 | 3,333 |